Logo image of CGNT

COGNYTE SOFTWARE LTD (CGNT) Stock Fundamental Analysis

USA - NASDAQ:CGNT - IL0011691438 - Common Stock

8.6001 USD
+0.16 (+1.9%)
Last: 10/6/2025, 1:45:04 PM
Fundamental Rating

4

Taking everything into account, CGNT scores 4 out of 10 in our fundamental rating. CGNT was compared to 281 industry peers in the Software industry. CGNT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CGNT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CGNT had positive earnings in the past year.
In the past year CGNT had a positive cash flow from operations.
In the past 5 years CGNT reported 4 times negative net income.
CGNT had a positive operating cash flow in 4 of the past 5 years.
CGNT Yearly Net Income VS EBIT VS OCF VS FCFCGNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -0.92%, CGNT perfoms like the industry average, outperforming 55.87% of the companies in the same industry.
CGNT's Return On Equity of -2.22% is in line compared to the rest of the industry. CGNT outperforms 57.65% of its industry peers.
The Return On Invested Capital of CGNT (0.95%) is better than 61.92% of its industry peers.
Industry RankSector Rank
ROA -0.92%
ROE -2.22%
ROIC 0.95%
ROA(3y)-10.49%
ROA(5y)-6.29%
ROE(3y)-24.24%
ROE(5y)-14.49%
ROIC(3y)N/A
ROIC(5y)N/A
CGNT Yearly ROA, ROE, ROICCGNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

CGNT has a Operating Margin of 0.91%. This is in the better half of the industry: CGNT outperforms 60.85% of its industry peers.
Looking at the Gross Margin, with a value of 70.86%, CGNT is in line with its industry, outperforming 56.58% of the companies in the same industry.
CGNT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.91%
PM (TTM) N/A
GM 70.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y1.89%
CGNT Yearly Profit, Operating, Gross MarginsCGNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

CGNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CGNT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CGNT has more shares outstanding
CGNT has a worse debt/assets ratio than last year.
CGNT Yearly Shares OutstandingCGNT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CGNT Yearly Total Debt VS Total AssetsCGNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

CGNT has an Altman-Z score of 1.81. This is not the best score and indicates that CGNT is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.81, CGNT perfoms like the industry average, outperforming 44.13% of the companies in the same industry.
There is no outstanding debt for CGNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.81
ROIC/WACC0.1
WACC9.16%
CGNT Yearly LT Debt VS Equity VS FCFCGNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

CGNT has a Current Ratio of 1.34. This is a normal value and indicates that CGNT is financially healthy and should not expect problems in meeting its short term obligations.
CGNT's Current ratio of 1.34 is in line compared to the rest of the industry. CGNT outperforms 43.42% of its industry peers.
CGNT has a Quick Ratio of 1.26. This is a normal value and indicates that CGNT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CGNT (1.26) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.26
CGNT Yearly Current Assets VS Current LiabilitesCGNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.67% over the past year.
CGNT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -56.72% yearly.
Looking at the last year, CGNT shows a quite strong growth in Revenue. The Revenue has grown by 14.04% in the last year.
The Revenue has been decreasing by -5.17% on average over the past years.
EPS 1Y (TTM)66.67%
EPS 3Y-56.72%
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)14.04%
Revenue growth 3Y-9.56%
Revenue growth 5Y-5.17%
Sales Q2Q%15.52%

3.2 Future

Based on estimates for the next years, CGNT will show a very strong growth in Earnings Per Share. The EPS will grow by 116.87% on average per year.
Based on estimates for the next years, CGNT will show a small growth in Revenue. The Revenue will grow by 6.46% on average per year.
EPS Next Y257%
EPS Next 2Y160.28%
EPS Next 3Y116.87%
EPS Next 5YN/A
Revenue Next Year13.48%
Revenue Next 2Y12.38%
Revenue Next 3Y12.7%
Revenue Next 5Y6.46%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CGNT Yearly Revenue VS EstimatesCGNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100M 200M 300M 400M 500M
CGNT Yearly EPS VS EstimatesCGNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 43.00, which means the current valuation is very expensive for CGNT.
CGNT's Price/Earnings ratio is in line with the industry average.
CGNT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.86.
With a Price/Forward Earnings ratio of 21.16, CGNT is valued on the expensive side.
Based on the Price/Forward Earnings ratio, CGNT is valued a bit cheaper than the industry average as 74.73% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.32. CGNT is around the same levels.
Industry RankSector Rank
PE 43
Fwd PE 21.16
CGNT Price Earnings VS Forward Price EarningsCGNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CGNT is valued a bit cheaper than the industry average as 71.89% of the companies are valued more expensively.
CGNT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 58.49
EV/EBITDA 33.76
CGNT Per share dataCGNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

CGNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CGNT's earnings are expected to grow with 116.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y160.28%
EPS Next 3Y116.87%

0

5. Dividend

5.1 Amount

CGNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COGNYTE SOFTWARE LTD

NASDAQ:CGNT (10/6/2025, 1:45:04 PM)

8.6001

+0.16 (+1.9%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-09 2025-09-09/bmo
Earnings (Next)12-09 2025-12-09/bmo
Inst Owners75.01%
Inst Owner Change0%
Ins Owners4.61%
Ins Owner Change0%
Market Cap627.55M
Analysts77.78
Price Target10.2 (18.6%)
Short Float %0.59%
Short Ratio1.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)726.33%
Min EPS beat(2)180.11%
Max EPS beat(2)1272.55%
EPS beat(4)4
Avg EPS beat(4)451.11%
Min EPS beat(4)157.67%
Max EPS beat(4)1272.55%
EPS beat(8)8
Avg EPS beat(8)677.79%
EPS beat(12)10
Avg EPS beat(12)456.1%
EPS beat(16)12
Avg EPS beat(16)299.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-0.74%
Max Revenue beat(2)-0.31%
Revenue beat(4)0
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-0.74%
Max Revenue beat(4)-0.31%
Revenue beat(8)2
Avg Revenue beat(8)-0.21%
Revenue beat(12)4
Avg Revenue beat(12)-0.48%
Revenue beat(16)5
Avg Revenue beat(16)-3.06%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-21.74%
EPS NQ rev (3m)-47.06%
EPS NY rev (1m)12.6%
EPS NY rev (3m)12.6%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)0.83%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 43
Fwd PE 21.16
P/S 1.67
P/FCF 58.49
P/OCF 23.79
P/B 3.09
P/tB 8.84
EV/EBITDA 33.76
EPS(TTM)0.2
EY2.33%
EPS(NY)0.41
Fwd EY4.73%
FCF(TTM)0.15
FCFY1.71%
OCF(TTM)0.36
OCFY4.2%
SpS5.16
BVpS2.78
TBVpS0.97
PEG (NY)0.17
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.92%
ROE -2.22%
ROCE 1.2%
ROIC 0.95%
ROICexc 1.35%
ROICexgc 3.89%
OM 0.91%
PM (TTM) N/A
GM 70.86%
FCFM 2.85%
ROA(3y)-10.49%
ROA(5y)-6.29%
ROE(3y)-24.24%
ROE(5y)-14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y1.89%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 127.27%
Cap/Sales 4.16%
Interest Coverage 250
Cash Conversion 167.59%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.26
Altman-Z 1.81
F-Score7
WACC9.16%
ROIC/WACC0.1
Cap/Depr(3y)75.65%
Cap/Depr(5y)79.28%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.67%
EPS 3Y-56.72%
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y257%
EPS Next 2Y160.28%
EPS Next 3Y116.87%
EPS Next 5YN/A
Revenue 1Y (TTM)14.04%
Revenue growth 3Y-9.56%
Revenue growth 5Y-5.17%
Sales Q2Q%15.52%
Revenue Next Year13.48%
Revenue Next 2Y12.38%
Revenue Next 3Y12.7%
Revenue Next 5Y6.46%
EBIT growth 1Y138.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year303.46%
EBIT Next 3Y75.38%
EBIT Next 5Y60.6%
FCF growth 1Y84.03%
FCF growth 3YN/A
FCF growth 5Y-6.04%
OCF growth 1Y67.47%
OCF growth 3Y161.04%
OCF growth 5Y-6.98%